Martin Schlumberger Selected Research

medullary Thyroid cancer

2/2022	Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives.
1/2021	Long-term follow-up and safety of vandetanib for advanced medullary thyroid cancer.
1/2020	Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial.
1/2017	Chemotherapy and tyrosine-kinase inhibitors for medullary thyroid cancer.
1/2016	Management of advanced medullary thyroid cancer.
1/2016	A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer.
11/2015	[Not Available].
4/2015	Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort.
7/2014	Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours.
11/2013	Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Schlumberger Research Topics

Disease

118	Thyroid Neoplasms (Thyroid Cancer) 10/2022 - 01/2002
68	Neoplasms (Cancer) 07/2022 - 01/2002
37	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2003
14	medullary Thyroid cancer 02/2022 - 05/2003
12	Papillary Thyroid Cancer 07/2022 - 01/2005
12	Disease Progression 11/2021 - 02/2008
9	Carcinoma (Carcinomatosis) 01/2018 - 12/2002
8	Lymphatic Metastasis 01/2011 - 08/2002
7	Anaplastic Thyroid Carcinoma 12/2021 - 11/2004
6	Adrenocortical Carcinoma 02/2015 - 01/2006
6	Adenoma (Adenomas) 11/2009 - 03/2004
5	Pheochromocytoma 01/2019 - 10/2007
5	Diarrhea 01/2019 - 02/2015
5	Hypertension (High Blood Pressure) 01/2018 - 02/2015
4	Paraganglioma (Paragangliomas) 12/2017 - 10/2007
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2017 - 01/2003
4	Fatigue 04/2017 - 02/2015
4	Papillary Carcinoma 04/2009 - 03/2004
4	Hypothyroidism 03/2006 - 01/2003
3	Proteinuria 01/2021 - 12/2015
3	Body Weight (Weight, Body) 12/2019 - 06/2013
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 05/2008
3	Carcinogenesis 01/2018 - 07/2005
3	Follicular Adenocarcinoma 07/2005 - 08/2002
2	Pain (Aches) 09/2021 - 09/2013
2	Heart Failure 01/2021 - 03/2006
2	Hyperthyroidism 01/2019 - 01/2005
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 03/2012
2	Asthenia 04/2017 - 02/2015
2	Exanthema (Rash) 04/2017 - 12/2015
2	Obesity 11/2015 - 08/2015
2	Thyroid Nodule (Nodule, Thyroid) 03/2013 - 01/2009
2	Cushing Syndrome 09/2011 - 01/2006
2	Breast Neoplasms (Breast Cancer) 01/2011 - 09/2003
2	Hyperplasia 12/2002 - 04/2002
2	Infections 08/2002 - 01/2002

Drug/Important Bio-Agent (IBA)

35	IodineIBA 10/2022 - 01/2002
19	Thyroglobulin FDA Link 08/2021 - 08/2002
15	lenvatinibIBA 01/2022 - 01/2015
13	Thyroid HormonesIBA 01/2021 - 08/2002
12	vandetanib (ZD6474)IBA 11/2021 - 02/2010
12	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2019 - 01/2002
10	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2019 - 01/2003
9	Thyrotropin Alfa FDA LinkGeneric 01/2021 - 01/2003
9	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2019 - 02/2004
8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 05/2008
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
8	Phosphotransferases (Kinase)IBA 01/2021 - 01/2005
8	Sorafenib (BAY 43-9006)FDA Link 12/2019 - 08/2011
8	Mitotane (Lysodren)FDA Link 01/2018 - 01/2006
7	Pharmaceutical PreparationsIBA 01/2021 - 06/2008
6	Biomarkers (Surrogate Marker)IBA 02/2022 - 02/2009
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2009
6	Tyrosine Kinase InhibitorsIBA 01/2017 - 09/2011
5	Hormones (Hormone)IBA 12/2019 - 01/2005
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2018 - 09/2011
5	sodium-iodide symporter (sodium iodide symporter)IBA 01/2017 - 01/2002
4	IodidesIBA 03/2007 - 01/2002
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 02/2015
3	Capsules (Microcapsules)IBA 10/2017 - 11/2004
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017 - 03/2010
3	Alanine Transaminase (SGPT)IBA 01/2016 - 02/2010
3	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2013 - 01/2005
3	AntibodiesIBA 08/2012 - 02/2004
3	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2012 - 11/2004
2	fluorocholineIBA 09/2021 - 01/2018
2	Radium-223IBA 09/2021 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2019 - 07/2010
2	RacivirIBA 01/2018 - 07/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 03/2010
2	Carcinoembryonic AntigenIBA 01/2016 - 02/2008
2	Angiopoietin-2IBA 01/2016 - 08/2015
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2015 - 02/2015
2	Biological ProductsIBA 08/2015 - 05/2003
2	Dual OxidasesIBA 04/2015 - 04/2006
2	Charcoal (Charbon)IBA 03/2015 - 09/2009
2	Iodine-131IBA 02/2015 - 03/2007
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 12/2014 - 10/2007
2	Sunitinib (Sutent)FDA Link 04/2014 - 04/2011
2	Galectin 3 (LGALS3)IBA 03/2013 - 12/2002
2	Cisplatin (Platino)FDA LinkGeneric 06/2012 - 11/2004
2	Ethiodized Oil (Ethiodol)FDA Link 03/2012 - 10/2010
2	VaccinesIBA 07/2010 - 08/2002
2	Messenger RNA (mRNA)IBA 03/2010 - 03/2004
2	Iodide Peroxidase (Deiodinase)IBA 03/2007 - 04/2006
2	Transcription Factors (Transcription Factor)IBA 04/2006 - 12/2002
2	PPAR gammaIBA 07/2005 - 09/2004
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2003 - 02/2002

Therapy/Procedure

43	Therapeutics 07/2022 - 08/2002
15	Radiotherapy 01/2018 - 09/2003
13	Thyroidectomy 09/2021 - 12/2002
7	Neck Dissection (Radical Neck Dissection) 03/2019 - 05/2003
6	Drug Therapy (Chemotherapy) 01/2017 - 01/2003
6	Lymph Node Excision (Lymph Node Dissection) 11/2012 - 05/2003
3	Aftercare (After-Treatment) 01/2018 - 09/2003
2	Contraindications 01/2019 - 10/2013
2	Drug Tapering 01/2019 - 01/2018
2	Tattooing 03/2015 - 09/2009
2	Nuclear Power Plants 11/2014 - 08/2012
2	Molecular Targeted Therapy 01/2012 - 12/2009